Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Why won’t unproven COVID treatments go away?

J. Leonard Lichtenfeld, MD
Conditions
January 6, 2021
138 Shares
Share
Tweet
Share

A recent conversation among a group of physicians gave me a fair amount of distress and discomfort.

The topic was an unproven treatment for COVID-19. The discomfort was the disinformation — in my opinion — being shared. The distress was that the discussion likely reflected what some doctors are actually doing for the treatment of patients infected with the coronavirus. Evidence was left at the doorstep.

As I reflected on the conversation, I realized it was not unlike what I have experienced over decades as a medical oncologist, especially in years past where there was literally very little if anything we could do for most patients with advanced cancer after our limited treatment options were exhausted.

Almost inevitably, as the end of the journey approached, there would be pleas for “one more thing,” or “can’t you try another treatment?” to save the life of a loved one. And, almost equally, when another treatment was tried, it was futile. In fact, I cannot remember a single instance when a “miracle cure” or treatment had any positive effect under those circumstances.

Now we find ourselves in the era of COVID-19. In some respects, we have seen the same scenario play out on a much more rapid and much larger scale: millions of people have been infected, many have recovered uneventfully while hundreds of thousands, if not more, have gone on to have serious illness, some surviving, some not.

And in all of this, there is the inevitable question: “Doctor, can’t you do something?”

The better news today compared to the early days of the pandemic — when we really could do nothing and knew much more than nothing — is that there are treatments and approaches we can offer which do help reduce the odds of death for many people with COVID.

We have a better idea of the risk factors. We have a better idea of when someone will benefit from hospitalization. We have a better idea of how to care for patients in the hospital. And yes, we do have better ideas of what treatments really do offer benefit.

But along the way, we have also learned what treatments don’t make much difference, based on the best studies we can perform, which are not perfect, but when taken in totality show, there really isn’t much evidence of benefit for certain medicines. And, yet, those treatments continue to be touted as life-saving or disease altering, evidence to the contrary notwithstanding.

That’s the part I don’t get: If the evidence shows some treatments don’t work, or they may not accomplish what people thought they would, then why do many clinicians continue to tout their absent effectiveness?

My oncology experience suggests that when little can be offered, there is an assumption there is always something out there that will make a difference. Sometimes, there is something out there: a new drug or other therapy in a clinical trial, for example.

Sadly, many times there are not. Yet hope and prayer demand, we try treatments even when we know the chances of success are very limited, if any at all.

Which brings me to an article recently published online in JAMA that frames this dilemma in terms of “sensible medicine.”

The core of the discussion:

The natural response at the bedside of a patient with COVID-19 is to act and to act decisively. Imbued with determination, clinicians seek to make a difference for patients who are seriously ill. In 2012, Taleb described an ‘illusion of control that leads to a default to action rather than inaction.’ For many medical emergencies … this illusion is a reality for clinicians because immediate intervention can prevent avoidable death. But what if it is unclear what to do? What if no medication or device will lead to a cure? Should clinicians do something, when the best option may be measured or supportive care? During the COVID-19 pandemic, clinicians’ tension between interventionism and measured action is ever-present.

The authors go on to outline several elements of “sensible medicine,” including:

  • Medicine Without Magic
  • Practice Doing (Almost) Nothing
  • Elevate Usual Care
  • Focus on High-quality Evidence
  • Think Bayesian (that’s statistical jargon to deal with the reality that although “new treatments are a bit like the proverbial new kid on the block: they have an allure that is hard to resist.” But in reality, the odds of their success is low.)

The authors continue: “It should follow that treatment guidelines, national mandates, and bedside care adapt to new data only when the evidence is rigorous, reproducible, and sufficiently strong.”

Those are important messages based on lessons learned from so many past experiences. To date, the overwhelming evidence is that we don’t have a single magic bullet that is going to make a big difference in the treatment of COVID-19 — at least, not yet. We will get there, hopefully, sooner rather than later.

In the meantime, we have learned through careful analysis which medicines do have some benefit and which do not.

Although that inconvenient truth may not be in synch with our innate desire as doctors to “do something,” we must avoid the allure of the shiny object on the hill, one where we convince ourselves that if a particular treatment was used just a bit differently, it would give us the golden results we seek.

Cancer has taught us a lot. It has taught us about devastating illness, where we cannot offer everything possible to save a life. It has taught us time and again that although miracles can happen, they don’t often happen (at least in the past, before the current era of targeted and immunotherapies). Cancer has taught us that careful research, careful analysis, and careful clinical trials can indeed make a genuine difference in outcomes for those with certain cancers.

In many ways, COVID is similar to cancer, except that the progress we have made against COVID over the past several months has been remarkably swift, even if, at times, it does not feel that way.

We need to keep that progress in mind and not succumb to the siren song of the magicians who would have us believe — just as with cancer — that they have a miracle drug or cure that has eluded everyone else, and has escaped recognition notwithstanding multiple trials which have failed to show benefit.

Miracles in medicine usually don’t happen miraculously. They usually happen from patience and perseverance. We can never forget the need to be sensible in moments of extreme desperation.

A “hail Mary” in medicine — just as in football or basketball — rarely changes the outcome of the game.

J. Leonard Lichtenfeld is an oncologist who blogs at Dr. Len’s Blog.

Image credit: Shutterstock.com 

Prev

Knowledge is power: Why science and health literacy matters

January 6, 2021 Kevin 1
…
Next

How the lessons from breast cancer saved this physician from burnout

January 6, 2021 Kevin 0
…

Tagged as: COVID, Infectious Disease

Post navigation

< Previous Post
Knowledge is power: Why science and health literacy matters
Next Post >
How the lessons from breast cancer saved this physician from burnout

More by J. Leonard Lichtenfeld, MD

  • How can we improve the quality of medications?

    J. Leonard Lichtenfeld, MD
  • Sunscreens: The balancing act between safety and cancer prevention

    J. Leonard Lichtenfeld, MD
  • It’s time we get the technology working for the patients, and not make their lives more difficult

    J. Leonard Lichtenfeld, MD

Related Posts

  • How COVID is exposing poor working conditions in the U.S.

    Irene Martinez, MD
  • A patient’s COVID-19 reflections

    Michele Luckenbaugh
  • COVID-19 shows why we need health insurance

    Jingyi Liu, MD
  • Finding happiness in the time of COVID

    Anonymous
  • Birthing in the era of COVID

    Jennifer Roelands, MD
  • How to get patients vaccinated against COVID-19 [PODCAST]

    The Podcast by KevinMD

More in Conditions

  • Changing the pediatric care landscape: Integrating behavioral and mental health care

    Hilary M. Bowers, MD
  • Unlocking the secret to successful weight loss: Curiosity is the key

    Franchell Hamilton, MD
  • The teacher who changed my life through reading

    Raymond Abbott
  • Revaluating mental health assessments: It’s not just the patient you should consider

    Tomi Mitchell, MD
  • Breaking down barriers: How technology is improving diabetes management in underserved communities

    Anonymous
  • Yoga and self-care won’t cure my Crohn’s disease

    Kristen L. Cole
  • Most Popular

  • Past Week

    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • Healing the damaged nurse-physician dynamic

      Angel J. Mena, MD and Ali Morin, MSN, RN | Policy
    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • From physician to patient: one doctor’s journey to finding purpose after a devastating injury

      Stephanie Pearson, MD | Physician
    • Breaking the stigma: Addressing the struggles of physicians

      Jean Antonucci, MD | Physician
    • Breaking the cycle of misery in medicine: a practical guide

      Paul R. Ehrmann, DO | Physician
  • Past 6 Months

    • The hidden dangers of the Nebraska Heartbeat Act

      Meghan Sheehan, MD | Policy
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • Why are doctors sued and politicians aren’t?

      Kellie Lease Stecher, MD | Physician
  • Recent Posts

    • Unlock the power of physician compensation data in contract negotiations [PODCAST]

      The Podcast by KevinMD | Podcast
    • From pennies to attending salaries: Why physicians should teach their kids financial literacy

      Michele Cho-Dorado, MD | Finance
    • From solidarity to co-liberation: Understanding the journey towards ending oppression

      Maiysha Clairborne, MD | Physician
    • Changing the pediatric care landscape: Integrating behavioral and mental health care

      Hilary M. Bowers, MD | Conditions
    • Contract Diagnostics is the only firm 100 percent dedicated to physician contract reviews

      Contract Diagnostics | Sponsored
    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • Pregnant, Black? Here's Your Drug Test
  • Progestin-Only Birth Control Linked to Small Increase in Breast Cancer Risk
  • Fatty Acid Tube Feeding May Backfire for Preemie Breathing Disorder
  • Case Reports Detail Vision Loss Linked to Recalled Artificial Tears
  • Admin Trumps Med Students: Anti-Abortion Group Allowed on Campus

Meeting Coverage

  • Outlook for Itchy Prurigo Nodularis Continues to Improve With IL-31 Antagonist
  • AAAAI President Shares Highlights From the 2023 Meeting
  • Second-Line Sacituzumab Govitecan Promising in Platinum-Ineligible UC
  • Trial of Novel TYK2 Inhibitor Hits Its Endpoint in Plaque Psoriasis
  • Durable Vitiligo Responses With Topical Ruxolitinib
  • Most Popular

  • Past Week

    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • Healing the damaged nurse-physician dynamic

      Angel J. Mena, MD and Ali Morin, MSN, RN | Policy
    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • From physician to patient: one doctor’s journey to finding purpose after a devastating injury

      Stephanie Pearson, MD | Physician
    • Breaking the stigma: Addressing the struggles of physicians

      Jean Antonucci, MD | Physician
    • Breaking the cycle of misery in medicine: a practical guide

      Paul R. Ehrmann, DO | Physician
  • Past 6 Months

    • The hidden dangers of the Nebraska Heartbeat Act

      Meghan Sheehan, MD | Policy
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • Why are doctors sued and politicians aren’t?

      Kellie Lease Stecher, MD | Physician
  • Recent Posts

    • Unlock the power of physician compensation data in contract negotiations [PODCAST]

      The Podcast by KevinMD | Podcast
    • From pennies to attending salaries: Why physicians should teach their kids financial literacy

      Michele Cho-Dorado, MD | Finance
    • From solidarity to co-liberation: Understanding the journey towards ending oppression

      Maiysha Clairborne, MD | Physician
    • Changing the pediatric care landscape: Integrating behavioral and mental health care

      Hilary M. Bowers, MD | Conditions
    • Contract Diagnostics is the only firm 100 percent dedicated to physician contract reviews

      Contract Diagnostics | Sponsored
    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds

MedPage Today Professional

An Everyday Health Property Medpage Today iMedicalApps
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...